Cerecin is a global healthcare company with almost 20 years of innovation in leadership and brain health.
At Cerecin we think differently. We develop novel evidence-based solutions that help people; pharmaceuticals, medical foods, diagnostics, medical devices and e-health products. These solutions target conditions ranging from memory impairment to some of the most devastating neurological diseases.
Cerecin is headquartered in Singapore and the USA, and our therapies are developed for person around the world.
Through our proprietary scientific platform, Cerecin is developing therapies that address metabolic deficiencies and provide alternative energy sources for brain cells. Our first product, Axona®, is a medical food intended for the clinical dietary management of the metabolic processes associated with mild to moderate Alzheimer's disease.
Cerecin recognizes that patients with CNS disorders need effective, well-tolerated therapies, and we hope that our novel therapeutic approaches positively impact these patients and their families. We are committed to improving the care and quality of life of patients.